drugset / Trial / NCT07235137

A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults

NCT07235137

Phase 1 Completed 12 enrolled Pfizer
NaSingle-groupOpen-labelBasic science

Summary

A study to learn how the study medicine called Ibuzatrelvir is taken up into the blood in healthy Chinese adults.

Timeline

Start
2025-10-16
Primary completion
2025-11-21
Completion
2025-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuzatrelvir Small molecule Oral

Indications

No indication recorded.